Announcements Trials
Browse Landscape

Phase

Phase 2 36Phase 3 17Phase 1/2 6Phase 1 6Phase NA 2Phase 4 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 5Breast Neoplasms 5Small Cell Lung Carcinoma 3Thoracic Neoplasms 2Ovarian Neoplasms 2Neuroendocrine Tumors 2Neoplasms 2Lung Diseases 2Carcinoma, Large Cell 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Retinoblastoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non-small Cell Lung Cancer Metastatic 1Non-Small Cell Lung Cancer Metastatic 1Neoplasms, Second Primary 1Neoplasms by Site 1Nasopharyngeal Neoplasms 1NSCLC 1Medulloblastoma 1Carcinoma, Squamous Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Bronchogenic 1Carcinoma 1Cancer Therapy-related Cardiovascular Toxicity 1Bronchial Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Pemetrexed 2endostar protein 1Erlotinib Hydrochloride 1Endostatins 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Adenocarcinoma of Lung × Carboplatin × Clear all
NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Anhui Provincial Hospital

Phase 4 Unknown
100 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡